Flawed studies informed recommendations against CYP2D6 testing for tamoxifen treatment, new study finds

A recent Mayo Clinic study has found that clinical recommendations discouraging the use of CYP2D6 genetic testing to advise tamoxifen treatment in women with breast cancer should be reconsidered because some of the studies the recommendations were based on had flawed methodology. The article, published in the January issue of the Journal of the National Cancer Institute, found that some … Read More

Falls among elderly increase over 12-year period

One of the most serious health concerns for the elderly seems to be becoming more common. A recent study out of the University of Michigan has found that self-reported falls among Americans 65 years and older increased by about 8 percent between 1998 and 2000. The researchers report that a greater increase in falls was seen than what would have … Read More

More research needed to find genetic link to depression risk

Parsing out the genetic underpinnings of depression remains a challenge for researchers, despite the rise in the number of studies focusing on the human genome, the authors of a new scientific review article report. The researchers behind the article, published in the January issue of the Harvard Review of Psychiatry, reviewed a number of studies on the genetic link to … Read More

Genelex announces new genetic testing options

Genelex is excited to announce the next chapter in the company’s ongoing mission to improve patient care and reduce adverse drug events. Genelex is unveiling five new panels and 17 new genetic testing options to augment our existing panel of six tests that form the core of the YouScript Personalized Prescribing System. In conjunction with the YouScript Personalized Prescribing software, … Read More